Advantage Alpha Capital Partners’s Teladoc Health TDOC Stock Holding History

Advantage Alpha Capital Partners’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-27,332	Closed	-$5.22M	–	90
2020 Q2	$5.22M	Buy	27,332 +4,413	+19%	+$773K	1.22%	39
2020 Q1	$3.55M	Sell	22,919 -17,384	-43%	-$2.02M	1.27%	30
2019 Q4	$3.37M	Buy	+40,303	New	+$3.07M	0.91%	56

Other funds holding TDOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

DVF

Discovery Value Fund Singapore $39.8M AUM 27.89% 1-Year Est. Return

Advantage Alpha Capital Partners's TDOC Position: Q3 2020 in Review

Advantage Alpha Capital Partners sold out of Teladoc Health (TDOC) in Q3 2020, closing a stake of 27,332 shares — an estimated $5.22M sold.

Advantage Alpha Capital Partners first reported a position in TDOC in Q4 2019 and held it in 3 quarters. The position peaked at $5.22M in Q2 2020. 743 funds tracked by Wall St. Rank hold TDOC as of Q3 2020.

Advantage Alpha Capital Partners reported no remaining Teladoc Health position as of Q3 2020 after selling out during the quarter.
Advantage Alpha Capital Partners sold 27,332 Teladoc Health shares in Q3 2020, an estimated $5.22M.
Advantage Alpha Capital Partners first reported a position in Teladoc Health in Q4 2019 and held it in 3 quarters.
Advantage Alpha Capital Partners's Teladoc Health position peaked at $5.22M in Q2 2020.
743 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2020.

Based on Advantage Alpha Capital Partners's 13F filing for Q3 2020, filed 16 Nov 2020.